Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Finasteride doesn't affect erections much, but may decrease libido in men.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Low testosterone may increase COVID-19 severity in men.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Hair loss needs more research for better treatments.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Using skin stem cells and certain molecules might lead to scar-free skin healing.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Finasteride is effective for hair loss and prostate issues but may cause lasting side effects.

Vitex negundo may help treat PCOD, but more human studies are needed.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Blocking adenosine A2B receptor may prevent or treat hearing loss.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.